基于功能性肺回避的个体化放射治疗:双盲随机对照试验结果
该双盲随机对照试验纳入27例接受同步放化疗的III期非小细胞肺癌(或根治性治疗的寡转移)患者,比较基于3He磁共振成像(MRI)的功能性肺回避放疗计划与标准计划。放疗后3个月FACT-L肺癌亚量表(LCS)评分两组相似(标准组17.4±2.8 vs 回避组17.3±6.1,P=.485),LCS评分临床意义下降≥3分的比例分别为50%(4/8)和33%(4/12)(P=.648)。试验因入组缓慢提前关闭,未达目标样本量64例。
要点
- 放疗后3个月LCS评分标准组17.4±2.8 vs 回避组17.3±6.1,P=.485。
- LCS评分下降≥3分者标准组50%(4/8) vs 回避组33%(4/12),P=.648。
- 两组各有2例发生≥2级放射性肺炎,无≥4级毒性。
核心结论
- 尽管该试验未完成全部入组,两组生活质量评分非常相似。
- 由于3He MRI稀缺,其他更常用的功能肺测量方法如4维计算机断层扫描通气图可考虑用于功能性肺回避放疗评估,需要更大规模多中心方法入组足够患者来检验此类方法。
研究设计与样本
- 双盲随机对照试验,计划入组64例,实际随机27例(标准组11例,回避组16例),因入组慢于预期提前关闭。
- 纳入III期非小细胞肺癌(或根治性治疗的寡转移)接受同步放化疗、吸烟史至少10包年的患者。
- 治疗前进行3He MRI测量肺通气,随机前创建标准计划(未使用3He MRI)和回避计划(优先保护通气良好肺)。
- 除负责导出所选计划的物理师外,所有参与者对分组设盲。
- 主要终点为放疗后3个月患者报告的FACT-L肺癌亚量表(LCS)生活质量;次要终点包括其他生活质量指标、毒性和生存结局。
主要发现
- 放疗后3个月平均±标准差LCS评分:标准组17.4±2.8 vs 回避组17.3±6.1(P=.485)。
- 预设LCS评分临床意义下降≥3分:标准组50%(4/8) vs 回避组33%(4/12)(P=.648)。
- 两组各有2例发生≥2级放射性肺炎,无≥4级毒性。
- 基线患者特征均衡良好。
临床怎么用
- 作者认为,由于3He MRI稀缺,其他更常用的功能肺测量方法如4维计算机断层扫描通气图可考虑用于功能性肺回避放疗评估。
- 作者认为,需要更大规模多中心方法入组足够患者来检验此类方法。
局限性
- 试验未完成全部入组,因入组慢于预期提前关闭,实际随机27例,目标入组64例。
- 3He MRI稀缺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether functional lung avoidance based on 3He magnetic resonance imaging (MRI) improves quality of life (QOL) for patients undergoing concurrent chemoradiotherapy (CCRT) for advanced non-small cell lung cancer. METHODS AND MATERIALS: Patients with stage III non-small cell lung cancer (or oligometastatic disease treated with curative intent) undergoing CCRT with at least a 10 pack-year smoking history were eligible. Patients underwent pretreatment 3He MRI to measure lung ventilation and had 2 radiation therapy (RT) plans created before randomization: a standard plan, which did not make use of the 3He MRI, and an avoidance plan, preferentially sparing well-ventilated lung. All participants were masked to assignment except the physicist responsible for exporting the selected plan. The primary end point was patient-reported QOL measured at 3-months post-RT by the FACT-L lung cancer subscale (LCS); secondary end points included other QOL metrics, toxicity, and survival outcomes. Target accrual was 64. RESULTS: Twenty-seven patients were randomized before the trial was closed due to slower-than-expected accrual, with 11 randomized to the standard arm and 16 to the avoidance arm. Baseline patient characteristics were well-balanced. At 3 months post-RT, the mean ± SD LCS scores were 17.4 ± 2.8 versus 17.3 ± 6.1 for the standard and avoidance arms, respectively (P = .485). A clinically meaningful, prespecified decline of ≥3 points in the LCS score was observed in 50% (4/8) in the standard arm and 33% (4/12) in the avoidance arm (P = .648). Two patients in each arm developed grade ≥2 radiation pneumonitis, with no grade ≥4 toxicities. CONCLUSIONS: Although this trial did not reach full accrual, QOL scores were very similar between arms. Due to the scarcity of 3He MRI, other, more commonly available methods to measure functional lung, such as 4-dimensional computed tomography ventilation mapping, may be considered in the assessment of functional lung avoidance RT, and a larger, multicenter approach would be needed to accrue sufficient patients to test such approaches.
引用
- Yaremko BP, Capaldi DPI, Sheikh K, et al. Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2022. PMID: 35550405. doi:10.1016/j.ijrobp.2022.04.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。